BCR-ABL1 kinase domain mutation analysis by next generation sequencing detected additional mutations in chronic myeloid leukemia patients with suboptimal response to imatinib.

ABSTRACT:

SUBMITTER: Benjamin ESB 

PROVIDER: S-EPMC7611165 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature